Identification of a possible somatic BRCA1 mutation affecting translation efficiency in an early-onset sporadic breast cancer patient

被引：7

作者：

Papa, S

Seripa, D

Merla, G

Gravina, C

Giai, M

Sismondi, P

Rinaldi, M

Serra, A

Saglio, G

Fazio, VM ^{[1
]}

机构：

[1] IRCCS H Casa Sollievo Sofferenza, Lab Mol Oncol & Gen Therapy, I-71023 San Giovanni Rotondo, FG, Italy

[2] Univ Turin, Dept Clin & Biol Sci, Turin, Italy

[3] Biomed Sch Med, Rome, Italy

来源：

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1998年 / 90卷 / 13期

关键词：

D O I：

10.1093/jnci/90.13.1011

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1011 / 1012

页数：2

共 50 条

[21] Identification of a BRCA2 mutation in a Turkish family with early-onset breast cancer
Celik, Elifnaz
Tekkus, Kubra Ermis
Akcay, Izzet Mehmet
Sal, Gizem Alkurt
Ezberci, Fikret
Doganay, Gizem Dinler
Doganay, Levent
CLINICAL CASE REPORTS, 2018, 6 (09): : 1751 - 1755
[22] Impact of BRCA1 mutation on survival after early onset breast cancer
T Huzarski
T Byrski
J Gronwald
B Górski
W Domagała
C Cybulski
Ping Sun
O Oszurek
M Szwiec
K Gugała
M Stawicka
Z Morawiec
T Mierzwa
H Janiszewska
E Kilar
E Marczyk
B Kozak-Klonowska
M Siołek
D Surdyka
R Wiśniowski
M Posmyk
J Lubiński
SA Narod
Hereditary Cancer in Clinical Practice, 10 (Suppl 4)
[23] BRCA1 MUTATION TESTING - RESULTS FROM 68 EARLY-ONSET BILATERAL BREAST-CANCER FAMILIES
INGLES, SA
DIEP, A
XUE, SY
SHATTUCKEIDENS, D
SPARKES, R
HAILE, R
AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 354 - 354
[24] Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing
Kim De Leeneer
Ilse Coene
Brecht Crombez
Justine Simkens
Rudy Van den Broecke
Alain Bols
Barbara Stragier
Ilse Vanhoutte
Anne De Paepe
Bruce Poppe
Kathleen Claes
Breast Cancer Research and Treatment, 2012, 132 : 87 - 95
[25] Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing
De Leeneer, Kim
Coene, Ilse
Crombez, Brecht
Simkens, Justine
Van den Broecke, Rudy
Bols, Alain
Stragier, Barbara
Vanhoutte, Ilse
De Paepe, Anne
Poppe, Bruce
Claes, Kathleen
BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (01) : 87 - 95
[26] Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations
Dite, GS
Jenkins, MA
Southey, MC
Hocking, JS
Giles, GG
McCredie, MRE
Venter, DJ
Hopper, JL
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (06) : 448 - 457
[27] Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer
Peto, J
Collins, N
Barfoot, R
Seal, S
Warren, W
Rahman, N
Easton, DF
Evans, C
Deacon, J
Stratton, MR
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (11) : 943 - 949
[28] Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status
Haffty, BG
Harrold, E
Khan, AJ
Pathare, P
Smith, TE
Turner, BC
Glazer, PM
Ward, B
Carter, D
Matloff, E
Bale, AE
Alvarez-Franco, M
LANCET, 2002, 359 (9316): : 1471 - 1477
[29] MUTATIONS IN THE BRCA1 GENE IN FAMILIES WITH EARLY-ONSET BREAST AND OVARIAN-CANCER
CASTILLA, LH
COUCH, FJ
ERDOS, MR
HOSKINS, KF
CALZONE, K
GARBER, JE
BOYD, J
LUBIN, MB
DESHANO, ML
BRODY, LC
COLLINS, FS
WEBER, BL
NATURE GENETICS, 1994, 8 (04) : 387 - 391
[30] De novo BRCA2 mutation in a patient with early-onset breast cancer.
Robson, M
Scheuer, L
Baum, R
Hull, J
McDermott, D
Pierce, H
Nafa, K
Ellis, N
Offit, K
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 90 - 90

← 1 2 3 4 5 →